BIOMARKERS APPLICABLE FOR DIAGNOSING HEPATIC FIBROSIS

摘要

FIELD: medicine.SUBSTANCE: invention refers to diagnostic techniques for hepatic fibrosis in an individual involving urokinase plasminogen, matrix metalloproteinase 9 and ?-2-microglobulin expression tests to derive a score and to diagnose. Also, the present invention refers to a diagnostic kit for hepatic fibrosis comprising a first antibody specifically bound to an urokinase plasminogen activator (uPA), a second antibody specifically bound to matrix metalloproteinase 9 (MMP9) and a third antibody specifically bound to ?-2-microglobulin (?-2-MG).EFFECT: higher diagnostic accuracy.17 cl, 33 tbl, 3 ex